Evidence map›Paper›PMID 41799815›Full record

ArticleFrontiers in psychiatry2026

Validation of the Psychopathic Processing and Personality Assessment in the Czech Republic.

Ivan Sebalo, Martina Sebalo Vňuková, Martin Anders

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ivan SebaloDepartment of Psychiatry, First Faculty of Medicine Charles University and General Teaching Hospital, Prague, Czechia.
Martina Sebalo VňukováDepartment of Psychiatry, First Faculty of Medicine Charles University and General Teaching Hospital, Prague, Czechia.
Martin AndersDepartment of Psychiatry, First Faculty of Medicine Charles University and General Teaching Hospital, Prague, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to validate the Czech-language Psychopathic Processing and Personality Assessment (PAPA) by examining its factor structure and psychometric properties in a non-forensic community sample in the Czech Republic. Methods: The study included 1013 adult participants (51.73% male, 48.27% female) with an average age of 42.14 years (SD = 8), drawn from the general population of Czech parents with at least one child. Participants completed the PAPA, a 29-item self-report questionnaire. The sample was divided into two groups for exploratory (n=304) and confirmatory factor analysis (n=709). Data were analysed using Principal Component Analysis (PCA) and Confirmatory Factor Analysis (CFA) to identify and validate the factor structure. Results: The exploratory analysis suggested a three-factor solution comprising hostile attitudes, manipulativeness, and callous-unemotional traits, which was confirmed through CFA. The model demonstrated acceptable fit indices (CFI, RMSEA, SRMR), indicating a robust structure for both male and female participants. Internal consistency for the factors ranged from acceptable to good. Conclusions: The validation of PAPA in Czech revealed a three-factor structure consistent with core psychopathy traits. This tool provides a reliable measure for assessing psychopathy in the Czech general population, highlighting cultural and sex-specific nuances in psychopathy assessment. Future research should explore the inclusion of the boldness dimension and validate the tool in forensic settings.

Indexed as

cross-cultural validationpsychopathic processing and personality assessment (PAPA)psychopathy traitssex-specific structuresthree-factor solution

Identifiers

PMID41799815
PMCPMC12964200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.